← Leaderboards
David Danforth
Clinical Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularDuctal EpitheliumBreastGene ExpressionDuctal Epithelial CellCytologyCell LineEndoscopyMonitorLaboratory StudyMolecular ProfilingDuct (Organ) StructurePathway InteractionsEpithelial CellsGene Expression ProfileGene Expression ProfilingMammary Gland ParenchymaBreast Cancer PreventionClassificationDesignHigh Risk WomanCharacteristicsIrrigationProtocols Documentation
Grant awards (24)
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$200,422
ZIA · FY2023 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$449,713
ZIA · FY2022 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$499,518
ZIA · FY2021 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$498,834
ZIA · FY2020 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$487,731
ZIA · FY2019 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$440,432
ZIA · FY2018 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$432,142
ZIA · FY2017 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$452,027
ZIA · FY2016 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$460,041
ZIA · FY2015 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$464,117
ZIA · FY2014 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$417,700
ZIA · FY2013 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$453,659
ZIA · FY2012 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$425,671
ZIA · FY2011 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$418,324
ZIA · FY2010 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$480,075
ZIA · FY2009 · CA · contact PI
Molecular Characterization of Breast Duct Epithelium at Risk for Breast Cancer$432,302
Z01 · FY2008 · CA · contact PI
Characterization and Regulation of High Risk and Malignant Breast Epithelium$961,249
Z01 · FY2007 · CA · contact PI
Characterization and Regulation of High Risk and Maligna$0
Z01 · FY2006 · SC · contact PI
Characterization and Regulation of High Risk and Maligna$0
Z01 · FY2005 · SC
Regulation of High Risk and Malignant Breast Epithelium$0
Z01 · FY2004 · SC
Characterization and Regulation of High Risk and Maligna$0
Z01 · FY2003 · SC
Characterization and Regulation of High Risk and Maligna$0
Z01 · FY2002 · SC
High Risk /Malignant Breast Epithelium--Character. /Reg.$0
Z01 · FY2001 · SC
Tamoxifen and Retinoid Regulation of Breast Epithelial Cell Growth and Metabolis$0
Z01 · FY2000 · SC